OOIR: Observatory of International Research

Papers

(The TQCC of Brain Tumor Pathology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation	47
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu	23
Preface for Brain Tumor Pathology vol.41 issue 2	21
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement	15
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis	14
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma	14
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature	14
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	14
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas	14
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma	14
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis	11
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment	11
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors	10
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development	10
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	10
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features	8
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation	8
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym	8
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles	7
Preface for Brain Tumor Pathology vol. 39 issue 2	7
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma	7
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis	7
Three-dimensional visualization of human brain tumors using the CUBIC technique	7
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas	6
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report	6

Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report